DAM
NRXPW

Deltec Asset Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Deltec Asset Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-28,350
Closed -$12K – 192
2017
Q4 		$12K Buy
+28,350
New +$10.8K ﹤0.01% 179

Other funds holding NRXPW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Deltec Asset Management's NRXPW Position: Q1 2018 in Review

Deltec Asset Management sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q1 2018, closing a stake of 28,350 shares — an estimated $12K sold.

Deltec Asset Management first reported a position in NRXPW in Q4 2017 and held it in 1 quarter. The position peaked at $12K in Q4 2017. 13 funds tracked by Wall St. Rank hold NRXPW as of Q1 2018.

  • Deltec Asset Management reported no remaining NRX Pharmaceuticals Warrant position as of Q1 2018 after selling out during the quarter.
  • Deltec Asset Management sold 28,350 NRX Pharmaceuticals Warrant shares in Q1 2018, an estimated $12K.
  • Deltec Asset Management first reported a position in NRX Pharmaceuticals Warrant in Q4 2017 and held it in 1 quarter.
  • Deltec Asset Management's NRX Pharmaceuticals Warrant position peaked at $12K in Q4 2017.
  • 13 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q1 2018.

Based on Deltec Asset Management's 13F filing for Q1 2018, filed 11 May 2018.